Revised French guidelines for the diagnosis and management of migraine in adults and children

The Journal of Headache and Pain

Methodology

Dominique Valade¹  Michel Lanteri-Minet²  Anne Donnet³  Christian Lucas⁴  Gilles Geraud⁵ 

[1] Centre Urgence Cephalees, Hopital Lariboisiere, 2, rue Ambroise-Pare, 75010, Paris, France;Departement d’Evaluation et de Traitement de la Douleur, Hopital Cimiez, 4, avenue Reine-Victoria, 06000, Nice, France;INSERM/UdA, U1107, Neuro-Dol, BP38, 8, place Henri-Dunant, 63001, Clermont-Ferrand, France;INSERM/UdA, U1107, Neuro-Dol, BP38, 8, place Henri-Dunant, 63001, Clermont-Ferrand, France;Centre d’Evaluation et de Traitement de la Douleur, Hopital Timone, 264, rue Saint-Pierre, 05 13385, Marseille cedex, France;Service de Neurologie et Pathologie Neurovasculaire, Hopital Salengro, rue Emile-Laine, 59037, Lille, France;Service de Neurologie, Hopital Rangueil, 170, avenue de Casselardit, 31300, Toulouse, France;

关键词: Migraine;    Sumatriptan;    Migraine Attack;    Zolmitriptan;    Rizatriptan;   

DOI  :  10.1186/1129-2377-15-2

 received in 2013-07-26, accepted in 2013-11-16,  发布年份 2014

来源: Springer

【 授权许可】

CC BY   
© Lanteri-Minet et al.; licensee Springer. 2014. This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.